Evidence map›Paper›PMID 33566203›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Long-term serological follow-up after primary Coxiella burnetii infection in patients with vascular risk factors for chronic Q fever.

Sheila B Buijs, Sanne K Stuart, Jan Jelrik Oosterheert, Steffi Karhof, Andy I M Hoepelman, Nicole H M Renders, André S van Petersen, Chantal P Bleeker-Rovers, Peter C Wever, Olivier H J Koning

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. No Influence of PreviousJournal of clinical medicine · 2022
    Article
  2. Molecular diagnosis ofAnnals of medicine · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Sheila B BuijsDepartment of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. sb.buijs1@gmail.com.ORCID http://orcid.org/0000-0003-3469-3063
Sanne K StuartDepartment of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Jan Jelrik OosterheertDepartment of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Steffi KarhofDepartment of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Andy I M HoepelmanDepartment of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Nicole H M RendersDepartment of Medical Microbiology and Infection Control, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
André S van PetersenDepartment of Surgery, Bernhoven Hospital, Uden, The Netherlands.
Chantal P Bleeker-RoversDepartment of Internal Medicine and Infectious Diseases, Radboud Expert Centre for Q Fever, Radboud University Medical Center, Nijmegen, The Netherlands.
Peter C WeverDepartment of Medical Microbiology and Infection Control, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Olivier H J KoningDepartment of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Jeroen Bosch Ziekenhuis · NLUtrecht University · NLRadboud University Nijmegen · NLZiekenhuis Bernhoven · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the long-term serological follow-up of patients with vascular risk factors for chronic Q fever that were previously Coxiella burnetii seropositive. C. burnetii phase I IgG titers were reevaluated in patients that gave informed consent or retrospectively collected in patients already deceased or lost to follow-up. Of 107 patients, 25 (23.4%) became seronegative, 77 (72.0%) retained a profile of past resolved Q fever infection, and five (4.7%) developed chronic Q fever. We urge clinicians to stay vigilant for chronic Q fever beyond two years after primary infection and perform serological testing based on clinical presentation.

Indexed as

Coxiella burnetiiAgedAntibodies, BacterialFemaleHumansImmunoglobulin GMaleMiddle AgedQ FeverRetrospective StudiesRisk FactorsAntibodies, BacterialImmunoglobulin GAneurysmBlood vessel prosthesisCoxiella burnetiiQ feverSerology

Identifiers

PMID33566203
PMCPMC8205920
OpenAlexW3126481756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.